CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-16 | Stone Paul A. Chief Financial Officer | Sale 10b5-1 | −100 | $26.40 | $3K | 19,103 |
| 2023-08-09 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +5,000 | $13.34 | $67K | 5,000 |
| 2023-08-09 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −5,000 | $25.09 | $125K | 0 |
| 2023-08-09 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 57,610 | ||
| 2023-08-09 | Stone Paul A. Chief Financial Officer | Sale 10b5-1 | −2,500 | $25.05 | $63K | 19,303 |
| 2023-07-10 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +4,485 | $7.01 | $31K | 4,485 |
| 2023-07-10 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +5,000 | $12.86 | $64K | 9,485 |
| 2023-07-10 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −9,485 | $23.00 | $218K | 0 |
| 2023-07-10 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,485 | 58,420 | ||
| 2023-07-10 | Throne Jason Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 58,750 | ||
| 2023-06-07 | SHANNON TIMOTHY M Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-07 | Hampton Malcolm Garret Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-07 | Kelley Susan L. Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-07 | MACKEY CATHERINE J Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-07 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-07 | ROSEN TERRY J Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-07 | Stein Jeffrey Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-07 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +16,200 | 16,200 | ||
| 2023-06-01 | Throne Jason Chief Legal Officer | Option exercise 10b5-1 | +3,553 | $7.01 | $25K | 3,553 |
| 2023-06-01 | Throne Jason Chief Legal Officer | Sale 10b5-1 | −3,553 | $23.02 | $82K | 0 |
Page 7 of 10 · 186 trades